Repeated Endobiliary Radiofrequency Ablation Plus Durvalumab, Gemcitabine, and Cisplatin for Unresectable Extrahepatic Cholangiocarcinoma

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(8 sites)

Japan

Aichi Medical University, Aichi

Nagoya City University Hospital, Aichi

Nagoya City University Midori Municipal Hospital, Aichi

Gifu University Hospital, Gifu

South Korea

Pusan National University Hospital, Busan

Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul

Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul

Severance Hospital, Yonsei University College of Medicine, Seoul